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Abstract 
Aminoglycoside antibiotics such as gentamicin have long been known to destroy cochlear and vestibular hair cells in vivo. In 
the cochlea outer hair cells are preferentially affected. In contrast, gentamicin will not damage outer hair cells in vitro unless it 
has been enzymatically converted to a cytotoxic metabolite. Several potential inhibitors of this enzymatic reaction were tested in 
an in vitro assay against outer hair cells isolated from the guinea pig cochlea. Viability of hair cells (viable cells as per cent of 
total number of cells observed) averaged about 70% under control conditions. Addition of metabolized gentamicin significantly 
reduced viability to less than 50% in one hour. Sulfhydryl compounds (glutathione, dithioerythritol) and antioxidants (vitamin C, 
phenylene diamine, trolox) prevented the cytotoxic actions of the gentamicin metabolite. Inhibitors of amine oxidases and 
compounds reportedly protective against renal and acute lethal toxicity of aminoglycosides (poly-I.-aspartate and pyridoxal 
phosphate, respectively) were ineffective as protectants. The results reinforce the hypothesis that gentamicin is enzymatically 
converted to a cytotoxin and imply the participation of sulfhydryl-sensitive groups or free radicals in this reaction. Alternatively 
or additionally, sulfhydryl compounds or antioxidants may participate in detoxification reactions. 
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1. Introduction 
Aminoglycoside antibiotics are essential drugs in 
therapy against gram-negative infections. The major 
side effects associated with aminoglycoside treatment 
both in patients and experimental animals are impair- 
ment of kidney and inner ear function. Histologically, 
drug-induced damage is manifested as progressive and 
irreversible destruction of the sensory cells of the 
vestibular and auditory systems whereby the .primary 
site of insult depends on the type of aminoglycoside. In 
the mammalian cochlea, outer hair cell death occurs 
first in the basal turn and progresses toward the apex. 
Correlating with the morphological damage, the sen- 
sorineural hearing loss begins in the higher frequen- 
cies, advances into the speech range and is most often 
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permanent (for reviews see Hawkins, 1976: Garetz and 
Schacht, 1994). 
Contrasting with the well-documented morphologi- 
cal and physiological pathology, attempts to establish a 
biochemical mechanism of the toxic action of these 
drugs have had limited success (Schacht, 1993; Garetz 
and Schacht, 1994). It was believed that aminoglycoside 
antibiotics did not require metabolism to exert either 
their therapeutic or deleterious effects. This notion 
was based largely on studies showing that the drugs 
were excreted in the urine apparently without being 
metabolized (Schentag and Jusko, 1977). However, it 
has been recently shown in our laboratory that gentam- 
icin does not of itself damage outer hair cells in vitro 
(Dulon et al., 1989). It is rendered acutely cytotoxic 
when first incubated with an enzyme preparation from 
liver (Huang and Schacht, 1990; Crann ct al., 1992) 
suggesting that an enzymatic reaction precedes the 
ototoxicity. This theory has opened new investigations 
into the characterization of the enzyme(s) involved, the 
reaction mechanism, the structure of the metabolitc 
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and its mechanism of action. Furthermore, it prompted 
the search for agents capable of blocking the cytotoxic 
mechanism at the enzymatic level (Garetz and Schacht, 
1992; Garetz et al., 1993). 
The current study reports on the efficacy of several 
compounds to interfere with hair cell destruction by 
the metabolite of gentamicin (tentatively termed 
‘gentatoxin’) in vitro. Drugs were chosen based on 
suspected properties of the enzymatic reaction and the 
toxic metabolite, and on previous attempts to amelio- 
rate aminoglycoside ototoxicity (Federspil, 1979; 
Schacht, 1993) or drug-induced nephrotoxicity (Kishore 
et al., 1992; Jones et al., 1992). In particular, we 
investigated sulfhydryl compounds, antioxidants and 
free-radical scavengers for their capacity to protect 
isolated outer hair cells from the acute cytotoxicity of 
gentatoxin. 
2. Materials and methods 
Preparation of the gentamicin metabolite 
Fresh guinea pig liver (pigmented guinea pigs from 
Murphy, Plainfield, NJ) and HBSS (Hanks’ Balanced 
Salt Solution without bicarbonate from Gibco Labora- 
tories, Grand Island, NY; buffered with 5 mM HEPES 
to pH 7.40, and osmolality adjusted to 300 mOsM with 
NaCl) were mixed 1: 3 (w/v> and homogenized with a 
Polytron (Brinkman, Westbury, NY) for 10 s. The 
suspension was centrifuged for 10 min at 1000 x g to 
remove nuclei and gross sediment, and the supernatant 
(‘post-nuclear fraction’) used for the incubation with 
gentamicin. Alternatively, liver was homogenized in 
HBSS in a teflon-glass homogenizer (two passes of the 
pestle at 1000 rpm), and a ‘cytosolic fraction’ was 
obtained by centrifugation at 10,000 x g for 20 min 
followed by centrifugation of the supernatant at 
100,000 x g for 90 min. The enzyme fractions were 
incubated for 1 hr at 37°C with or without 10 mM 
gentamicin as previously described (Huang and 
Schacht, 1990; Crann et al., 1992) and detailed in the 
figure legends. Reactions were terminated by heating 
at 55°C for 90 s. After 5 min on ice, precipitated 
proteins were removed by centrifugation at 10,000 x g 
for 10 min and the supernatants assayed directly or 
stored at -20°C for no longer than one week prior to 
use. 
Trolox was purchased from Aldrich Chemical Co 
(Milwaukee, WI), other chemicals from Sigma (St. 
Louis, MO). MDL 72-527 was a gift from Merrell Dow 
Research Laboratories, Cincinnati, OH. 
Toxicity assay with isolated outer hair cells 
Cochleae were immediately excised from decapi- 
tated guinea pigs and outer hair cells isolated essen- 
tially as described previously (Zenner et al., 1985; Zajic 
and Schacht, 1987). The sensory epithelium from the 
three upper turns was removed by microdissection, 
transferred into HBSS containing type IV collagenase 
(0.5 mg/ml; Sigma, St. Louis, MO) for 15 min after 
which cells were mechanically dissociated. For each 
assay, approximately 100 isolated hair cells were placed 
in a 45-~1 droplet of HBSS in a Petri dish with con- 
trolled humidity. Five ~1 of the deproteinated incuba- 
tion mixture were added yielding a final drug concen- 
tration of 1 mM. After 1 hr at room temperature, outer 
hair cells were carefully examined by light microscopy 
(20 X ) by a blinded observer. Cells were classified 
according to previously established morphological cri- 
teria (Zajic and Schacht, 1987) as either healthy (long, 
cylindrical cells with smooth cytoplasm and central 
nucleus) or damaged (ruptured, swollen, constricted 
with a displaced or absent nucleus). The percentage of 
healthy cells was the index of cell viability. 
3. Results 
Controls 
Outer hair cells exposed to HBSS alone or incuba- 
tion media without gentamicin generally maintained a 
viability of 65 to 75% following the isolation procedure 
and the subsequent l-h assay at room temperature 
(Figs. la, f, g, h; 2 and 3). Likewise, when gentamicin 
was added to the hair cell assay only and not to the 
preceding enzymatic incubation, cells maintained their 
normal appearance. However, when gentamicin was 
first metabolized, its addition decreased hair cell viabil- 
ity to approximately 40% within 1 h (Figs. 2 and 3). 
Both enzyme preparations, post-nuclear fraction and 
cytosol, were equally effective in converting gentamicin 
to a cytotoxin (Figs. 2 and 3). 
Each experiment included a negative control for the 
quality and viability of the hair cell preparation and a 
positive control (with gentamicin) for the successful 
formation of a cytotoxin. A typical experiment addi- 
tionally accommodated tests of a potential inhibitor 
with and without gentamicin for a total of four to eight 
Fig. 1. Effect of metabolized gentamicin on isolated outer hair cells. Gentatoxin was prepared by incubating gentamicin with a cytosolic fraction 
(see legend to fig. 3) and assayed against isolated hair cells as described in ‘Methods’. The same group of hair cells is seen exposed to toxin for 2 
min (panel a), 8 min (b), 14 min Cc), 35 min (d) and 45 min (e). Panels f, g and h show representative control cells exposed for 45 min to 
incubation medium to which gentamicin was added after incubation and heat precipitation of proteins. 
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Fig. 2. Sulfhydryl compounds protect from cytotoxicity. Reagents 
were incubated with a hepatic post-nuclear fraction and tested 
against isolated outer hair cells as described in ‘Methods’. The 
incubation medium contained the enzyme fraction, 100 mM sodium 
phosphate (pH 7.4), 4 mM NADPH, 30 mM KC1 and 7 mM MgCl,. 
Concentrations of gentamicin, glutathione or dithioerythritol were 10 
mM each. Results represent meansksd. of an average of 6 inde- 
pendent experiments on 918 cells (control: Ctrl), 753 cells (gentami- 
tin: Gm), 333 cells (giutathione: GSH), 533 cells (GSH plus gm), 359 
cells (dithioe~thrito~ DTE), and 788 cells (DTE plus Gmk Differ- 
ences between gentamicin and control, and between gentamicin 
alone and each genta~cin/drug combination were statistically sig- 
nificant at P < 0.01 (Fisher’s Least Significant Difference). 
conditions. Five to eleven independent experiments 
were performed to examine the efficacy of a drug as an 
inhibitor. 
A complication in assessing viability could arise if 
the toxin would reduce affected cells to debris which 
then might escape scoring. In this case, the total num- 
1 
Fig. 3. Antioxidants protect from cytotoxicity. Antioxidants were 
incubated with a hepatic cytosoi without added cofactors and tested 
against isoiated outer hair cells as described in ‘Methods’. Concen- 
trations in the incubations were 10 mM for all reagents except Trolox 
(4 mM). Results represent means ~fr s.d. of an average of 6 independ- 
ent experiments on 3739 cells (control: Ctrl), 3414 cells (gentamicin: 
Gm), 393 cells (phenylene diamine: PhD), 1049 cells (PhD plus Gm), 
667 cells (vitamin C: Vit C), 546 cells (Vit C plus Gm), 370 cells 
(trolox), 418 cells (0.25% methanol: MeOH; vehicle for trolox), and 
527 cells (trolox plus Gm). Differences between gentamicin and 
control, and between gentamicin alone and each gentamicin/drug 
combination were statistically significant at P < 0.01 Wisher’s Least 
Significant Difference). 
ber of cells observed in gentatoxin-treated incubations 
should be consistently and significantly lower. This. 
however, was not observed. Even within a limited num- 
ber of experiments (Fig. 31, total ceils in the absence 
and presence of toxin were within 10% of each other 
(3739 vs. 3424). 
Loss of viability was initially seen as granulation of 
the cell cytoplasm, loss of birefringence and swelling or 
distortion of the cylindrical shape (Figs. 1 a-e>. These 
changes became evident at different times in individual 
cells, visible in some after a few minutes (Figs. lb and 
c>, while other cells appeared normal throughout much 
of the assay period (Figs. 1 d and e). In the absence of 
gentatoxin, hair cells survived without apparent alter- 
ations of their morphology (Figs. If, g and h). 
Effects of suifhydryl compounds and antioxidants 
The morphology of hair cells remained unaffected 
by glutathione or dithioe~thrito~ or the antioxidants 
phenylene diamine, vitamin C or trolox. When these 
compounds were incubated with the enzymatic frac- 
tions in the absence of genta~cin and added to iso- 
lated hair cells, viability was maintained at control 
levels (Figs. 2 and 3). Vitamin C appeared to compro- 
mise cell integrity in some of the experiments, but the 
cumulative observations showed no significant differ- 
ence from controls. However, each one of these com- 
pounds prevented the expected decrease in viability 
when added to enzymatic incubations with gentamicin. 
All assays in the additional presence of the protective 
drugs differed significantly from assays with metabo- 
lized gentamicin alone and were not different from 
assays with the protective agents without gentamicin 
(Figs. 2 and 3). A quantitative difference between the 
tested agents could not be inferred from the results 
since all effects were of similar magnitude and drugs 
were only studied at a single concentration. Glycine, 
glutamate and cysteine, the amino acid constituents of 
glutathione, were tested in combination in two experi- 
ments (121 cehs) where they did not attenuate gentam- 
icin toxicity. 
In a related series of experiments, gIutathione or 
dithioe~thritol were absent from the enzymatic incu- 
bation with gentamicin but subsequently added to the 
hair cell assay. The resulting protective effect was 
similar to that achieved when these agents were in- 
cluded in the enzymatic incubation. Viability was main- 
tained at 63 k 10% in the presence of glutathione and 
at 62 + 14% in the presence of dithioerythritol (ob- 
servations on 669 and 586 cells, respectively). 
Other agents 
Inhibitors of polyamine and serum diamine oxi- 
dases, aminoguanidine and MDL 72-527, were incu- 
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bated and tested on 326 and 202 cells, respectively. At 
1 and 2 mM final concentrations, they were ineffective 
at preventing the cytotoxic actions of the gentamicin 
metabolite. 
Preliminary experiments also included agents previ- 
ously tested against other side effects of aminoglyco- 
sides. Pyridoxal phosphate can antagonize lethal ac- 
tions of gentamicin in the rat (Kenniston et al., 19871, 
and differential effects of poly-L-aspartate, poly-L- 
glutamate and poly-D-glutamate on renal aminoglyco- 
side toxicity have been reported &shore at al., 1992). 
Pyridoxal phosphate (10 mM) was investigated in six, 
each poly-amino acid (10 mM with respect to amino 
acid residues) in two experiments. None of these agents 
altered the toxicity of the gentamicin metabolite. 
4. Discussion 
Sulfhydryl compounds, antioxidants and free-radical 
scavengers protect isolated guinea pig outer hair cells 
from the damaging effects of the toxic gentamicin 
metabolite. At least two mechanisms can account for 
this effect. Firstly, the formation of the cytotoxin can 
be inhibited by these agents. In this case, sulfhydryl or 
disulfide groups (e.g. on enzymes) or free radicals 
should participate in the reaction converting gentam- 
icin to gentatoxin. This does not imply that the metabo- 
lite itself is a free radical. In fact, the ability to recover 
it from the incubation medium after heating or filtra- 
tion (Crann et al., 1992) would seem to argue against 
this. Peroxides or endoperoxides are examples of 
chemicals which are not radicals but whose formation 
is susceptible to the influence of radical scavengers and 
antioxidants. Such compounds can, in turn, generate 
free radicals and thus, initiate chain reactions that may 
lead to cell damage or cell death. 
Alternatively, the observed protection can arise from 
a detoxification of the cytotoxin rather than from the 
prevention of its formation. The fact that sulfhydryl 
reagents also prevent hair cell destruction when added 
after the enzymatic incubation makes detoxification a 
possibility. This sulfhydryl-mediated attenuation of tox- 
icity is intriguing in view of established cellular bio- 
chemical defense mechanisms. Glutathione, a thiol- 
containing tripeptide found in virtually all mammalian 
cells, plays a key role in a number of reactions related 
to detoxification of xenobiotics and protection against 
reactive oxygen species (Jakoby, 1978; Listowsky et al., 
1988; Meister, 1991). It is thus possible that glutathione 
inactivates the gentamicin metabolite in an enzymatic 
reaction involving glutathione transferase or glu- 
tathione peroxidase. This, however, remains specula- 
tive as it is currently unknown whether the inactivation 
proceeds enzymatically or non-enzymatically. Further- 
more, it is conceivable that the protective agents act at 
both the level of formation and detoxification of the 
gentamicin metabolite. 
Hypersensitivity to aminoglycoside-induced hearing 
loss has recently been linked to a mutation in a specific 
mitochondrial gene in several patient populations 
(Hutchin et al., 1993; Prezant et al., 1993). Until the 
functional consequences of this mutation are known, 
any association with the formation or inactivation of 
the proposed metabolite remains speculative. However, 
oxidative metabolism in mitochondria is the major 
source of reactive oxygen radicals; and mitochondria 
are a site of enzymes of detoxification and a major 
glutathione reserve. Enhanced mitochondrial leakage 
of reactive oxygen species or defects in detoxification 
mechanisms are possible links between mitochondrial 
DNA polymorphism and sensitivity to aminoglycosides. 
While the reaction mechanisms of gentamicin 
metabolism remain speculative, at least one pathway 
may be ruled out. Aminoglycosides are structurally 
characterized by the presence of primary and sec- 
ondary amine groups. Thus, they could serve as sub- 
strates for enzymes of amine or polyamine metabolism 
yielding, for example, reactive aldehydes. The inability 
of oxidase inhibitors to prevent cytotoxicity makes this 
possibility unlikely. 
In addition to ototoxic side effects, the spectrum of 
aminoglycoside toxicity includes acute effects and 
chronic renal impairment. There is evidence to suggest 
that the underlying mechanisms differ from one an- 
other (Schacht, 1993; Garetz and Schacht, 1994). The 
lack of protection afforded here by pyridoxal phos- 
phate, a blocker of acute lethal toxicity (Kenniston et 
al., 1987), and poly-L-aspartate, a blocker of nephrotox- 
icity (Kishore et al., 1992) could be indicative of such a 
dissociation of acute, nephrotoxic and ototoxic mecha- 
nisms. It still remains possible, however, that these 
compounds exert their effects at different steps in the 
sequence of aminoglycoside toxicity. 
The successful protection of isolated hair cells from 
gentamicin cytotoxicity in vitro prompts the question of 
a possible protection against gentamicin ototoxicity in 
vivo. Attenuation of aminoglycoside ototoxicity by free 
radical scavengers has been claimed in animal experi- 
ments (Pierson and Moller, 1981) but has also met with 
failure (Bock et al., 1983). Likewise, sulfhydryl com- 
pounds have been employed in vivo with varying suc- 
cess and were eventually considered ineffective (re- 
viewed by Federspil, 1979). However, support for an 
influence of glutathione in the expression of aminogly- 
coside toxicity has come from experiments with the 
glutathione-synthesis inhibitor buthionine sulfoximide. 
Lowering of glutathione levels with this drug in guinea 
pigs potentiated the ototoxicity caused by the com- 
bined administration of the aminoglycoside kanamycin 
and the diuretic ethacrynic acid (Hoffman et al., 1988). 
Preliminary experiments suggest that the converse is 
true, namely attenuation of ototoxicity by elevating 
glutathione levels (Garetz et al., 1993, 1994). This 
renders the current in vitro observations relevant for 
both the elucidation of mechanisms of gentamicin 
metabolism and therapeutic intervention in aminogly- 
coside ototoxicity. 
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